Impact of Netrin-1 in the Pathophysiology of Placenta Accreta Spectrum
NCT ID: NCT04628169
Last Updated: 2024-09-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2021-01-01
2023-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Netrin-1 and Placenta Accreta
NCT04683562
Management of Placenta Accreta Spectrum
NCT04609527
Placenta Accreta Spectrum Protocol
NCT04384510
Evaluating Placental Thickness and Thickness of Uterine Muscle at Placenta Attachment in Prediction of Postpartum Blood Loss in Placenta Accreta
NCT06351969
Outcomes of Placenta Accreta Spectrum Disorders Surgery in Relation to Placenta Accreta Scoring Index
NCT06220760
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To correlate their expression with the demographic parameters.
* To assess the correlation between their expression in PAS specimens.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group A
30 placental specimens of PAS
no intervention applied
no intervention applied
group B
30 placental specimens of heaithy women with normal pregnancy
no intervention applied
no intervention applied
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention applied
no intervention applied
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnancy associated with morbid conditions such as hypertension, diabetes mellitus, autoimmune disease, cardiac disease, renal disease, history of anemia, blood transfusion, other blood diseases and endocrinal disease; fetal distress or intrauterine growth retardation.
* uterine scar pregnancies were excluded
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hanaa Mohammed Mohammed Sayed
assistant lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hanaa Mohammed Mohammed Sayed
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
netrin-1 in placenta accreta
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.